Join Date
October 2024
Country
Gender
Not Specified
Age
Not Specified
About Ryan Kellogg
Dr. Kellogg’s struggle with a mystery illness led him to pioneer technology for measuring thousands of molecules in self-collected blood microsamples. This allows for a better understanding of health fluctuations and the impacts of health interventions in detail. When combined with wearable sensors and symptom tracking, this technology allows for real-time health monitoring and pattern discovery with unprecedented resolution. PhD in Microfluidics and Systems Biology from ETH Zurich.
Companies & Work
RTHM
Current Description: RTHM provides virtual-first care for complex illness including Long COVID, ME/CFS, POTS, and mast cell activation. Many clinics focus on teaching patients how to better cope with symptoms, which is helpful, but we don’t stop there. We develop collaborations & partnerships so our patients access to the most promising testing and root-cause directed early therapies for their illness(es) with the goal of simplifying and streamlining the most efficient and effective clinical pathways so they can be scaled in the form of low cost online modules overseen remotely by clinicians.
In conjunction with clinical care, RTHM operates a clinical lab and collects deep molecular data with robust clinical context to develop AI-powered diagnostics and better ways of predicting which treatments may work best for whom.
In conjunction with clinical care, RTHM operates a clinical lab and collects deep molecular data with robust clinical context to develop AI-powered diagnostics and better ways of predicting which treatments may work best for whom.
